Skip to content

AnaptysBio, Inc. ANAB Tax on Share Settlement

Tax on Share Settlement at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$73.2M+1,602%
Biogen logo
BiogenBIIB
$55.1M+127%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.07M+129%
Precigen logo
PrecigenPGEN
$146K-69.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$6.99M+482%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.7B+180%

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s tax on share settlement?
AnaptysBio, Inc. (ANAB) reported tax on share settlement of $0 in Q1 2026.
How has AnaptysBio, Inc.'s tax on share settlement changed year-over-year?
AnaptysBio, Inc.'s tax on share settlement decreased by 100.0% year-over-year, from $1.45M to $0.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.